Recombinant production and purification of the human protein Tau

Luca Ferrari, Stefan G D Rüdiger*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Tau protein is a microtubule-stabilising protein whose aggregation is linked to Alzheimer's Disease and other forms of dementia. Tau biology is at the heart of cytoskeletal dynamics and neurodegenerative mechanisms, making it a crucial protein to study. Tau purification, however, is challenging as Tau is disordered, which makes it difficult to produce in recombinant system and is degradation-prone. It is thus challenging to obtain pure and stable preparations of Tau. Here, we present a fast and robust protocol to purify Tau recombinantly in Escherichia coli. Our protocol allows purifying Tau either tag-less or FLAG-tagged at its N-terminus, and Tau fragments of interest. By exploiting a cleavable affinity tag and two anion exchange columns, we obtained Tau preparations of high purity, stable and suitable for in vitro studies, including aggregation experiments that resemble neurodegenerative processes.
Original languageEnglish
Pages (from-to)447-455
Number of pages9
JournalProtein Engineering, Design and Selection
Volume31
Issue number12
DOIs
Publication statusPublished - 1 Dec 2018

Keywords

  • Alzheimer’s disease
  • neurodegeneration
  • protein aggregation
  • protein purification/intrinsically disordered protein
  • protein aggregate
  • recombinant protein
  • tau protein
  • amino acid sequence
  • biosynthesis
  • chemistry
  • genetic engineering
  • genetics
  • human
  • isolation and purification
  • mutation
  • procedures

Fingerprint

Dive into the research topics of 'Recombinant production and purification of the human protein Tau'. Together they form a unique fingerprint.

Cite this